Trade Bayer AG - BAYN CFD

Market is not available at the momentMarket information is presented
as of 2026-05-22 15:26:27
Trading Conditions
Type
This financial instrument is available for trading through CFDs and Knock-outs.

Knock-out options available only for selected countries.
Learn more about:CFDsKnock-outs
Spread0.2
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
€1,000.00
Overnight funding adjustment
Charges from full value of position
-0.016602 %
(-€0.83)

Trade size with leverage ~ €5,000.00

Money from leverage ~€4,000.00


-0.01660%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
€1,000.00
Overnight funding adjustment
Charges from full value of position
-0.005621 %
(-€0.28)

Trade size with leverage ~ €5,000.00

Money from leverage ~€4,000.00


-0.00562%
Overnight funding adjustment time21:00 (UTC)
CurrencyEUR
Min traded quantity1
Margin20.00%
Stock exchangeGermany
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close38.8
Open38.75
1-Year Change63.16%
Day's Range38.35 - 38.95

Trade Bayer AG - BAYN CFD

Browse our live chart to get all the information you need on the Bayer share price today.

Bayer AG (BAYN) is a multinational pharmaceutical and life sciences company. Comprising over 350 companies, it operates as one of the world's largest chemical manufacturers. The business is producing and marketing innovative products in four core segments: human and veterinary pharmaceuticals; consumer healthcare products; agricultural chemicals, seeds and biotechnology products.

The company is headquartered in Leverkusen, Germany, and has operations in nearly every country in the world with a majority of its business in Europe, North America and the Far East. At the end of 2019, Bayer had a team of over 100,000 employees working worldwide. The firm is among industry leaders in research and development, spending nearly 12 per cent of its revenues on this segment.

The business is included in the Fortune Global 500 list of the world’s largest companies.

Bayer shares are listed on the Frankfurt Stock Exchange under the ticker symbol BAYN. The company is a constituent of the Euro Stoxx 50 Index and the DAX 30 Index.

Follow the ups and downs of the Bayer share price in euro with Capital.com to spot the best trading opportunities.

Founded in 1863, Bayer was part of chemicals giant IG Farben in 1925-52, and then returned to being an independent company. The new millennium saw the landmark acquisition of Schering in 2006 – the largest takeover in Bayer's history, and one of the biggest pharma mergers of all time. In September 2015, the company spun out its materials science division into a separate publicly-traded firm Covestro (1COV), retaining about a 70 per cent interest in the business.

On its website, Bayer explains that its innovative products are contributing to finding solutions to some of the world’s major challenges. The company says it is improving quality of life for a growing population by focusing its R&D on preventing, alleviating and treating diseases. It is also helping to provide a reliable supply of food, feed and plant-based raw materials.

In fact, this 150-year-old company was the first in the world to introduce the flagship healthcare product aspirin. Today, the firm manufactures products that include anti-infectives, antibiotics, oncology, cardiovascular, central nervous system drugs, over-the-counter medications, diagnostics and animal-health products, as well as crop protection products, plastics and polyurethanes.

With Capital.com’s Bayer stock chart you can not only quickly view the current Bayer share price, but also trace the company’s shares value in historic terms. 

Bayer AG stock saw a period of almost uninterrupted growth from June 2012, when it traded at €46.87 per share, to April 2015, when it peaked at €143.88 per share. The stock then fell back to €82.79 per share in May 2016, right before recovering to hit €121.9 per share in 2017. 

However, the uplift was short-lived, and BAYN stock soon started to lose in value sharply, falling as low as €52.21 per share by June 14, 2019. The share price then retraced some of its losses to end the year at €72.81. On March 23, 2020, the stock closed the trading day at its multi-year lowest of €47.5 per share amid the broader market sell off caused by the Covid-19 pandemic outbreak and consequent economic uncertainty. 

Only a month later, in June 2020, BAYN shares were already hovering around the €70 level. Ever since, the Bayer stock price has experienced lots of volatility, characterised by multiple price fluctuations.

Stay up-to-date with the latest market news and watch the Bayer stock quote live at Capital.com.

Latest shares articles

Bayer stock forecast
Bayer stock forecast: Third-party price targets
Bayer (BAYN) is trading around €33.65 as of 10:48am on 4 December 2025 (UTC), moving between €33.55 and €34.60 on Capital.com’s share CFD feed. Past performance is not a reliable indicator of future results.
12:11, 10 December 2025
Round illuminated Campari sign mounted on a red wall with white Campari Milano branding
Davide Campari-Milano stock forecast: Q1 2026 earnings
Davide Campari-Milano is an Italian spirits group listed in Milan. Its Q1 2026 update showed 2.9% organic sales growth, below analyst estimates. Explore third-party CPR price targets and technical analysis. Past performance is not a reliable indicator of future results.
13:18, 21 May 2026
Deutz logo
DEUTZ stock forecast: Q1 2026 results
DEUTZ AG’s Q1 2026 results, released 7 May, shows new orders up 41.2% and revenue up 8.4%, as investors assess its new five-division structure and the impact of US import duties on customer pricing. Explore third-party DEZ predictions. Past performance is not a reliable indicator of future results.
13:02, 20 May 2026
Monte dei Paschi di Siena bank logo displayed on a wall sign
BCA MPS stock forecast: Mediobanca merger integration
Banca Monte dei Paschi di Siena reported Q1 2026 net profit of €521m, while Mediobanca integration continued after its completed takeover. Explore third-party BMPS price targets and technical analysis. Past performance is not a reliable indicator of future results.
10:43, 19 May 2026
Related News
Reuters NewsEurope
10:00 (UTC), 20 May 2026
Top cases on the US Supreme Court's docket
GlobeNewswireEurope
14:30 (UTC), 19 May 2026
Morgan & Morgan Wins Law Firm of the Year and 13 Other Law.com Awards
Public TechnologiesEurope
12:08 (UTC), 19 May 2026
Artiva Biotherapeutics names Diego Miralles president, head of R&D
Public TechnologiesEurope
06:30 (UTC), 19 May 2026
Bayer wins FDA priority review for asundexian to prevent secondary stroke
Public TechnologiesEurope
04:27 (UTC), 19 May 2026
Goldman Sachs lifts Bayer voting rights to 5.34% from 4.44%
Public TechnologiesEurope
20:02 (UTC), 18 May 2026
Evogene unit AgPlenus, Bayer discontinue herbicide development project
Reuters NewsEurope
19:34 (UTC), 18 May 2026
Bayer agrees to pay $133 million for PCB cleanup in two states
Reuters NewsEurope
12:35 (UTC), 18 May 2026
Bayer - FDA Priority Review For Sevabertinib

User feedback and ratings

Read the feedback from our clients1, whatever their experience level.
2025-07-01
P**** R******

I'm learning the basics of stock investing. This platform is clear and pretty good. I've been using it for over 6 months.

2025-07-01
V***** F******* N***** S****

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-06-30
B******

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-06-27
G** G******

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-24
R**************

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-06-22
J*** A.

The app is built to make options and figures easy to understand, great for beginners and intermediate traders. Demo accounts are simple to set up. 100:1 leverage is available.

2025-06-22
D******

Deposits and withdrawals work without issues. Very low spreads. No noticeable fees. Easy to follow.

2025-06-19
d*********

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-06-16
f*********

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-05-29
C*********

Love the TV integration. Makes traders life smooth and comfortable.

2025-05-20
G****

I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!

2025-04-29
d******

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-02-06
N***** B***

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Three steps to get started

1. Create your account (subject to eligibility)2. Deposit on your terms3. Trade when you’re ready